Valuation : Eckert & Ziegler SE

Market Cap 800M 930M 751M 687M 1.28B 87.93B 1.29B 8.88B 3.46B 44.94B 3.49B 3.42B 145B P/E 2026 *
15.6x
P/E 2027 * 14.7x
Enterprise Value 685M 796M 642M 588M 1.1B 75.21B 1.11B 7.6B 2.96B 38.44B 2.99B 2.92B 124B EV / Sales 2026 *
2.15x
EV / Sales 2027 * 1.98x
Free-Float
67.36%
Yield 2026 *
1.65%
Yield 2027 * 1.69%
1 day+2.56%
1 month+2.56%
Current year 12.29
Extreme 12.293
14.67
1 year 12.29
Extreme 12.293
14.67
3 years 12.29
Extreme 12.293
14.67
5 years 12.29
Extreme 12.293
14.67
10 years 12.29
Extreme 12.293
14.67
Manager TitleAgeSince
Chief Executive Officer 59 07/06/2023
Chief Tech/Sci/R&D Officer - 01/01/2025
Chief Operating Officer 59 01/01/2025
Director TitleAgeSince
Chairman 57 07/06/2023
Director/Board Member 66 01/01/2014
Director/Board Member 58 01/01/2017
Change 5-day change 1-year change 3-year change Capi.($)
+2.56%-.--% - - 925M
-0.49%-2.24%+24.90%-34.18% 17.63B
+1.44%-3.73%-33.99%+58.58% 1.61B
+0.31%-2.81%-23.64%+16.27% 925M
-1.29%-10.05%-50.09%-82.83% 957M
+0.03%-0.08%+67.65%-4.03% 778M
-1.58%-2.86%-33.86%-47.32% 681M
-0.92%+9.97%-38.45%-46.70% 606M
-0.38%+6.45%-32.02%-33.11% 490M
-3.58%-10.36%+80.25%+46.54% 427M
Average -0.35%+0.71%-4.36%-14.09% 2.68B
Weighted average by Cap. -0.22%+0.41%+14.08%-26.24%

Financials

2026 *2027 *
Net sales 318M 370M 298M 273M 510M 34.94B 514M 3.53B 1.37B 17.85B 1.39B 1.36B 57.5B 342M 397M 321M 293M 548M 37.55B 552M 3.79B 1.48B 19.19B 1.49B 1.46B 61.81B
Net income 51.68M 60.07M 48.5M 44.37M 82.82M 5.68B 83.47M 574M 223M 2.9B 226M 221M 9.35B 53.08M 61.7M 49.82M 45.58M 85.07M 5.83B 85.74M 589M 229M 2.98B 232M 227M 9.6B
Net Debt -116M -135M -109M -99.39M -186M -12.72B -187M -1.29B -500M -6.5B -505M -494M -20.93B -123M -142M -115M -105M -196M -13.46B -198M -1.36B -530M -6.88B -535M -523M -22.15B
Logo Eckert & Ziegler SE
Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
Employees
1,105
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
12.75EUR
Average target price
21.60EUR
Spread / Average Target
+69.41%

Annual profits - Rate of surprise